Skip to content

A2 Detached Dual Port System

by Therex Corp.

510(k) K950212

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

1 closed

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK950212 Date13 Apr 1995ClearedStatusActive

Recalls

1 recall · FDA

    • Terminated Z-0273-2007 FDA Unclassified (pre-2012) initiated 29 Sep 2006

    Catheter has separated from the infusion port body.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
LJT
Device Class
Class II
Regulation
21 CFR Part 880.5965
Advisory Committee
General Hospital
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The A2 Detached Dual Port System is a subcutaneous, implanted port and catheter device designed for intravascular access. It features a dual-port configuration, allowing simultaneous infusion or withdrawal of fluids through separate access points while remaining detached from the catheter hub, reducing the risk of contamination or occlusion.

This system is intended for use in general hospital settings and is supplied as a reusable medical device. It is regulated under FDA 510(k) clearance (K950212) and falls under product code LJT, classified as a Class II device. The device is manufactured by Therex Corp. and includes specific sizes such as 1.0mm and 1.8mm outer diameter polyurethane models, as referenced in related submissions.

Other devices from Therex Corp.

See all devices from Therex Corp. →

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the A2 Detached Dual Port System used for?

    The A2 Detached Dual Port System is designed for intravascular access in general hospital settings. Its dual-port configuration allows simultaneous infusion or withdrawal of fluids through separate access points, which helps minimize the risk of contamination or occlusion compared to single-port systems. This makes it particularly useful for patients requiring multiple treatments or monitoring simultaneously.

  • How is the A2 Detached Dual Port System supplied?

    This system is supplied as a reusable medical device. It is intended for repeated use within clinical settings, provided proper cleaning, sterilization, and maintenance protocols are followed. The reusable nature ensures cost-effectiveness and reduces waste, though it requires adherence to strict infection control measures.

  • What sizes are available for the A2 Detached Dual Port System?

    The A2 Detached Dual Port System is available in two primary outer diameter sizes: 1.0mm and 1.8mm polyurethane models. These variations allow for flexibility in patient-specific applications, accommodating different vascular access needs while maintaining compatibility with standard catheterization techniques.

  • Is the A2 Detached Dual Port System sterile?

    The device is not explicitly described as sterile in its supplied state, but as a reusable medical device, it must undergo thorough sterilization between uses. Proper sterilization protocols (e.g., autoclaving or chemical sterilization) are critical to ensure patient safety and prevent infection. Always follow manufacturer guidelines for sterilization and maintenance.

  • What regulatory pathway does the A2 Detached Dual Port System follow?

    The A2 Detached Dual Port System is regulated under the FDA’s 510(k) clearance pathway, specifically with clearance number K950212. It is classified as a Class II device under product code LJT, indicating it has been determined to be substantially equivalent to a legally marketed predicate device. This classification ensures it meets established safety and effectiveness standards for subcutaneous, implanted port and catheter systems.